Hamas says leadership survived Israeli attack in Doha, confirms six deaths    Saudi Crown Prince and Jordanian King back Qatar fully to preserve its sovereignty in phone call    Tunisian president meets Saudi foreign minister in Tunis Prince Faisal co-chairs Saudi-Tunisian Political Consultation Committee meeting    Saudi Arabia slams Israel's use of blockade and starvation as tactics to impose forceful displacement    PIF chief says Saudi transformation could outpace China's, outlines 'filtration' investment process The Fund to unveil its next five-year strategy soon    Arcapita acquires C&K Paving, expanding its global business services portfolio    Crown Prince to outline domestic and foreign policy priorities during Shoura Council address Wednesday    Hajj Ministry launches catering challenge to foster innovation in services to pilgrims    Israel carries out attack against Hamas leadership in Qatar    French PM François Bayrou loses crucial confidence vote in parliament    Anastacia: Arnold Schwarzenegger made me sing Whatta Man 12 times    Saudi Real GDP records growth of 3.9% in Q2 2025    PIF signs MoU with Macquarie Asset Management to boost investments in infrastructure and energy transition    Thousands pay their last respects to Giorgio Armani, private funeral on Monday    French doctor goes on trial for poisoning 30 patients, 12 fatally    The key to happiness    Gamers frustrated as Hollow Knight: Silksong crashes stores on launch    Mike Tyson and Floyd Mayweather Jr. set to meet in exhibition boxing match in 2026    Al Hilal sign Turkish defender Yusuf Akcicek on €22m deal until 2029    Al Qadsiah sign German midfielder Julian Weigl to strengthen defensive midfield    Al Ahli secure Flamengo starlet Matheus Gonçalves in long-term deal through 2027    Sholay: Bollywood epic roars back to big screen after 50 years with new ending    Ministry launches online booking for slaughterhouses on eve of Eid Al-Adha    Shah Rukh Khan makes Met Gala debut in Sabyasachi    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Moderna starts COVID-19 vaccine trial in infants and young children
Published in The Saudi Gazette on 16 - 03 - 2021

The first children have been vaccinated in Moderna's Phase 2/3 pediatric COVID-19 vaccine trial, the company announced Tuesday in a statement.
The clinical trial, called the KidCOVE study, will enroll approximately 6,750 children in the US and Canada between the ages of 6 months and 11 years old.
The trial is broken into two parts. In part one, different dosages of the vaccine are being tested on the children. Children between the ages of 6 months and 1 year old will receive two doses of the vaccine spaced about 28 days apart at either a 25 or a 50 or a 100 microgram level. Children between the ages of 2 and 11 will receive two doses of the vaccine spaced about 28 days apart at either a 50 or a 100 microgram level.
The findings of part one will be used to determine which dose will be used in part two. For part two, the trial will expand to include children who are given a saline placebo, which does nothing. The children will be followed for 12 months after their second injection.
Moderna is doing the tests to see if the vaccine protects children from getting sick if they come into contact with coronavirus, according to the clinical trial's patient information website.
"We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada," Moderna CEO Stéphane Bancel said in a press release.
"This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population."
The study is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, and the Biomedical Advanced Research and Development Authority at the US Department of Health and Human Services.
Moderna is not the only COVID-19 vaccine currently being tested in children, as the Pfizer/BioNTech COVID-19 vaccine is being studied in children as well. Johnson & Johnson has announced plans to study the vaccine in adolescents, ages 12 to 18.
In December, the US Food and Drug Administration authorized the emergency use of Moderna's COVID-19 vaccine for adults and of Pfizer/BioNTech's COVID-19 vaccine for people ages 16 and older.
In February, the FDA authorized the emergency use of Johnson & Johnson's vaccine for adults 18 and older. — Courtesy CNN


Clic here to read the story from its source.